Difficulty: Medium
Average Score: 82%
Practice
A woman who takes highly active antiretroviral therapy (HAART) for HIV/AIDS has become pregnant. What effect will the woman's pregnancy have on her drug regimen?
Correct answer
C
Rationale
The correct answer is C) She can continue her HAART unchanged.
Educational Rationale:
In early pregnancy, it is crucial for pregnant women living with HIV/AIDS to maintain their highly active antiretroviral therapy (HAART) to prevent transmission to the fetus. Discontinuing HAART (option A) can lead to increased viral loads and higher risk of transmission. Increasing dosages (option B) without medical supervision can result in adverse effects. However, simply continuing the HAART regimen unchanged (option C) ensures viral suppression and reduces the risk of vertical transmission. Discontinuing or changing components of HAART (option D) can compromise treatment efficacy. It is important for healthcare providers and patients to understand the significance of uninterrupted HAART during pregnancy to protect both the mother and the unborn child from potential complications associated with HIV/AIDS.
Educational Rationale:
In early pregnancy, it is crucial for pregnant women living with HIV/AIDS to maintain their highly active antiretroviral therapy (HAART) to prevent transmission to the fetus. Discontinuing HAART (option A) can lead to increased viral loads and higher risk of transmission. Increasing dosages (option B) without medical supervision can result in adverse effects. However, simply continuing the HAART regimen unchanged (option C) ensures viral suppression and reduces the risk of vertical transmission. Discontinuing or changing components of HAART (option D) can compromise treatment efficacy. It is important for healthcare providers and patients to understand the significance of uninterrupted HAART during pregnancy to protect both the mother and the unborn child from potential complications associated with HIV/AIDS.